SRRA
Sierra Oncology, Inc. Common Stock
SRRA
SRRA
Delisted
SRRA was delisted on the 30th of June, 2022.
34 hedge funds and large institutions have $169M invested in Sierra Oncology, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
+1
Holders Change %
+3.03%
% of All Funds
0.59%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
3
Increased
12
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
IC
Ikarian Capital
Dallas,
Texas
|
$10.6M |
2 |
![]()
Adage Capital Partners
Boston,
Massachusetts
|
$16.3M |
3 |
Northern Trust
Chicago,
Illinois
|
$750K |
4 |
BlackRock
New York
|
$419K |
5 |
OM
Opaleye Management
Boston,
Massachusetts
|
$3.22M |
Top Sellers
1 |
Millennium Management
New York
|
$2.07M |
2 |
TI
Telemetry Investments
New York
|
$241K |
3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
$1.18M |
4 |
PVI
Pura Vida Investments
New York
|
$1.46M |
5 |
Renaissance Technologies
New York
|
$2.07M |